gvtcx

supplier

Bristol Myers Squibb

UB81DH

as a supplier

15 recorded awards from 3 buyers , between 7 Feb 2022 and 6 Jul 2023.

awards won
15
exclusive
0%
0 sole-winner awards
median award
£428.2m
largest
£428.2m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared The NHS Commissioning Board (operating under the name of NHS England) · 1 Mar 2022
NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual shared The NHS Commissioning Board (operating under the name of NHS England) · 22 Feb 2022
NHS Framework Agreement for the Supply of Direct Oral Anticoagulant (DOAC) Medicines for the NHS in England shared The NHS Commissioning Board (operating under the name of NHS England) · 26 Nov 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche shared The NHS Commissioning Board (operating under the name of NHS England) · 2 Mar 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared The NHS Commissioning Board (operating under the name of NHS England) · 23 Feb 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared The NHS Commissioning Board (operating under the name of NHS England) · 23 Feb 2021

every contract won by Bristol Myers Squibb →